Novanta to present at the CJS Securities 18th Annual Investor Conference on Wednesday, January 10, 2018

BEDFORD, Mass., Dec. 28, 2017 /PRNewswire/ — Novanta Inc. (NASDAQ:NOVT) (the “Company” or “Novanta”), a trusted technology partner to medical and advanced technology equipment manufacturers, today announced that Matthijs Glastra, Chief Executive Officer, and Robert Buckley, Chief Financial Officer, will present at the CJS Securities 18th Annual New Ideas for the New Year Conference on Wednesday, January 10, 2018.    

About Novanta

Novanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary expertise in photonics, vision, and precision motion technologies with a proven ability to solve complex technical challenges. This enables Novanta to engineer mission-critical core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on NASDAQ under the ticker symbol “NOVT.”

Novanta Inc.
Investor Relations Contact:

Robert J. Buckley
(781) 266-5137

Novanta logo

SOURCE Novanta Inc.

PR Newswire

 
Article syndicated under licence from PR Newswire via QuoteMedia


About the author: PR Newswire provides electronic distribution, targeting, measurement and broadcast services on behalf of tens of thousands of corporate, government, association, labor, non-profit, and other customers worldwide. Using PR Newswire, these organizations reach a variety of audiences including the news media, the investment community, government decision-makers, and the general public with their up-to-the-minute, full text news provisioning. PR Newswire content is considered a mainstay among news reporters, investors and individuals who seek breaking news from the source.